On Wednesday May 31 (10:45–11:45 CEST), DHC Master Practice Expert Don Fink will be speaking on "The What, Why and When in your Bioassay Development Strategy" in a session moderated by Christopher Bravery.

On Friday June 2 our COO/MP Katy Spink will be speaking on "Required Infrastructure for Manufacturing Advanced Therapy Products at Mass Scale" as part of a Launch & Patient Access session chaired by Jon Rowley.

And then (because two Don Finks are better than one!), you can hear from Don yet again on Saturday June 3 (11:45-12:45 CEST) in the "Regulating Biological Ancillary Materials, Who’s Doing it Right?," moderated by Bryan Choi.

Reach out to us via the partnering system

And/or reach out to the BD team here